Unit­ed’s Mar­tine Roth­blatt en­dors­es a biotech uni­corn’s CEO and antes up for US rights to an IPF drug

Unit­ed Ther­a­peu­tics Mar­tine Roth­blatt has joined the pack of ad­mir­ers back­ing one of the in­dus­try’s most in­trigu­ing biotech uni­corns.

Just a few months af­ter gain­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.